
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
October 15th, 2024
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
October 15th, 2024
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 18th, 2024
Applied DNA Launches Mpox Clade I and Clade II Testing Service
September 17th, 2024
Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
September 17th, 2024
Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan
September 4th, 2024
Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 23rd, 2024
Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 19th, 2024
Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
August 8th, 2024
Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024
August 7th, 2024